Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
AstraZeneca
McKesson
Mallinckrodt

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MALARONE PEDIATRIC

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for Malarone Pediatric

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00298610 ↗ Safety and Efficacy Study of IV Artesunate to Treat Malaria Completed Military Infectious Diseases Research Program (MIDRP) Phase 2 2006-03-01 The purpose of this study is to determine how GMP IV Artesunate is metabolized and cleared by individuals with uncomplicated malaria infection and to determine how fast it eliminates malaria infection from the body.
NCT00298610 ↗ Safety and Efficacy Study of IV Artesunate to Treat Malaria Completed U.S. Army Medical Research and Development Command Phase 2 2006-03-01 The purpose of this study is to determine how GMP IV Artesunate is metabolized and cleared by individuals with uncomplicated malaria infection and to determine how fast it eliminates malaria infection from the body.
NCT00298610 ↗ Safety and Efficacy Study of IV Artesunate to Treat Malaria Completed U.S. Army Office of the Surgeon General Phase 2 2006-03-01 The purpose of this study is to determine how GMP IV Artesunate is metabolized and cleared by individuals with uncomplicated malaria infection and to determine how fast it eliminates malaria infection from the body.
NCT00421473 ↗ Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients Completed Radboud University Phase 4 2007-03-01 Malarone┬« (atovaquone/proguanil) is frequently used in malaria prophylaxis. Unfortunately, there are indications that certain anti-HIV agents may decrease atovaquone plasma levels by induction of atovaquone metabolism. For travelling HIV patients, the clinical consequences of these possible drug drug interactions are serious, since a diminished exposure to the anti-malarial drug will result in suboptimal prophylaxis of malaria and potential development of drug resistant strains of Plasmodium falciparum. The purpose of this study is to find out if HIV patients using HAART regimes with either lopinavir/ritonavir, atazanavir/ritonavir or efavirenz have lower atovaquone plasma levels than healthy volunteers after a single dose of atovaquone/proguanil.
NCT00444106 ↗ Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function Completed Novartis Phase 4 2007-05-01 To evaluate the potential effects of artemether- lumefantrine on the auditory function
NCT00984256 ↗ Weekly Dosing of Malarone ┬« for Prevention of Malaria Completed U.S. Army Medical Research and Development Command Phase 2 2009-09-01 The purpose of this study is to determine whether Malarone ┬«, which is a drug approved to prevent malaria when taken daily, will still effectively prevent malaria if taken weekly.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Malarone Pediatric

Condition Name

Condition Name for Malarone Pediatric
Intervention Trials
Malaria 13
Malaria,Falciparum 2
Exercise 1
PCP 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Malarone Pediatric
Intervention Trials
Malaria 16
Malaria, Falciparum 3
Infections 2
Infection 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Malarone Pediatric

Trials by Country

Trials by Country for Malarone Pediatric
Location Trials
Netherlands 8
United States 7
Kenya 1
Belgium 1
Colombia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Malarone Pediatric
Location Trials
Maryland 5
New York 1
Washington 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Malarone Pediatric

Clinical Trial Phase

Clinical Trial Phase for Malarone Pediatric
Clinical Trial Phase Trials
Phase 4 5
Phase 2 3
Phase 1/Phase 2 1
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Malarone Pediatric
Clinical Trial Phase Trials
Completed 18
Withdrawn 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Malarone Pediatric

Sponsor Name

Sponsor Name for Malarone Pediatric
Sponsor Trials
Radboud University 6
U.S. Army Medical Research and Development Command 3
Medicines for Malaria Venture 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Malarone Pediatric
Sponsor Trials
Other 31
U.S. Fed 8
Industry 5
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Boehringer Ingelheim
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.